
Sign up to save your podcasts
Or


Send us a text
Nick talks to Dr. Alan Davis, a clinical psychologist and Director of the Center for Psychedelic Drug Research & Education at Ohio State University. They discuss: the effectiveness of mainstream forms of psychotherapy and antidepressant medications (SSRIs) for depression; psychedelic medicine & psilocybin-assisted psychotherapy; the relevance of the subjective effects of psychedelics for their therapeutic effects; FDA approval for MDMA- and psilocybin-assisted psychotherapy in the coming years; and more.
*Not medical advice.
Support the show
Affiliates:
For all the ways you can support my efforts
By Nick Jikomes4.8
8181 ratings
Send us a text
Nick talks to Dr. Alan Davis, a clinical psychologist and Director of the Center for Psychedelic Drug Research & Education at Ohio State University. They discuss: the effectiveness of mainstream forms of psychotherapy and antidepressant medications (SSRIs) for depression; psychedelic medicine & psilocybin-assisted psychotherapy; the relevance of the subjective effects of psychedelics for their therapeutic effects; FDA approval for MDMA- and psilocybin-assisted psychotherapy in the coming years; and more.
*Not medical advice.
Support the show
Affiliates:
For all the ways you can support my efforts

4,998 Listeners

1,533 Listeners

1,919 Listeners

310 Listeners

1,231 Listeners

371 Listeners

5,306 Listeners

662 Listeners

29,193 Listeners

244 Listeners

184 Listeners

1,186 Listeners

115 Listeners

1,079 Listeners

74 Listeners